Prognostic significance of heat shock protein 90AA1 (HSP90α) in invasive breast cancer

Journal article


Alsaeed, S. A., Toss, M., Alsaleem, M., Aleskandarany, M., Chitra, J., Kurozumi, S., Ball, G., Mongan, N., Green, A. and Rakha, E. 2021. Prognostic significance of heat shock protein 90AA1 (HSP90α) in invasive breast cancer. Journal of Clinical Pathology. 75 (4), pp. 263-269. https://doi.org/10.1136/jclinpath-2020-207106
AuthorsAlsaeed, S. A., Toss, M., Alsaleem, M., Aleskandarany, M., Chitra, J., Kurozumi, S., Ball, G., Mongan, N., Green, A. and Rakha, E.
Abstract

Aims The mechanisms that drive breast cancer (BC) progression and poor outcome are not fully understood. The human heat shock protein 90 alpha family class A member 1 (HSP90α) encoded by the HSP90ΑA1 gene has a vital role in cellular responses to stress and is implicated in the development and progression of many cancers. The current study aims to explore the clinical and prognostic importance of HSP90α in BC.

Methods The Molecular Taxonomy of Breast Cancer International Consortium (n=1980); The Cancer Genome Atlas (n=1097) and the Breast Cancer Gene-Expression Miner (Bc-GenExMiner) BC datasets (n=5056) were used to evaluate HSP90ΑA1 mRNA expression. HSP90α protein expression was further assessed using immunohistochemistry in a large (n=911) well-characterised BC series. The association between mRNA and protein expressions with other clinicopathological parameters and outcome was analysed.

Results High expression of HSP90ΑA1 both at the mRNA and protein levels was significantly associated with characteristics of BC poor prognosis, including high grade, lymphovascular invasion, poor Nottingham Prognostic Index and positive expression of p53 and PIK3CA. Outcome analysis revealed that high HSP90α protein expression is an independent predictor of shorter BC-specific survival.

Conclusion HSP90α can be used as a potential prognostic marker in BC. Further mechanistic studies are warranted to determine the underlying molecular mechanisms mediated by HSP90α in BC.

Keywordsbreast diseases; breast neoplasms; lymph nodes; molecular;; pathology
Year2021
JournalJournal of Clinical Pathology
Journal citation75 (4), pp. 263-269
PublisherBMJ Journals
ISSN1472-4146
Digital Object Identifier (DOI)https://doi.org/10.1136/jclinpath-2020-207106
Web address (URL)https://jcp.bmj.com/content/75/4/263.long
Output statusPublished
Publication dates25 Mar 2021
Publication process dates
Accepted23 Jan 2021
Deposited08 Apr 2025
Supplemental file
File Access Level
Controlled
Permalink -

https://repository.derby.ac.uk/item/9z06v/prognostic-significance-of-heat-shock-protein-90aa1-hsp90-in-invasive-breast-cancer

  • 9
    total views
  • 0
    total downloads
  • 9
    views this month
  • 0
    downloads this month

Export as

Related outputs

SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer
Alfarsi, L. H., Ansari, R. E., Erkan, B., Fakroun, A., Craze, M. L., Aleskandarany, M., Cheng, K. W., Ellis, I. O., Rakha, E. A. and Green, A. R. 2025. SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer. Scientific Reports. 15 (2805), pp. 1-16. https://doi.org/10.1038/s41598-025-87292-1
Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer
Aleskandarany, M. 2024. Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer. BJC Reports. pp. 1-10. https://doi.org/10.1038/s44276-024-00097-z
GraphX-Net: A Graph Neural Network-Based Shapley Values for Predicting Breast Cancer Occurrence
Basaad, A., Basurra, S., Vakaj, E. and Aleskandarany, M. 2024. GraphX-Net: A Graph Neural Network-Based Shapley Values for Predicting Breast Cancer Occurrence. IEEE Access. 12, pp. 93993 - 94007. https://doi.org/https://doi.org/10.1109/ACCESS.2024.3424526
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
Althobiti, M., El-sharawy, K. A., Joseph, C., Aleskandarany, M., Toss, M. S., Green, A. R. and Rakha, E. A. 2021. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer. Breast Cancer Research and Treatment. 189 (3), pp. 621-630. https://doi.org/10.1007/s10549-021-06336-y
Hypoxia drives Centrosome amplification in cancer cells via HIF1α-dependent induction of polo-like kinase 4
Aleskandarany, M. 2021. Hypoxia drives Centrosome amplification in cancer cells via HIF1α-dependent induction of polo-like kinase 4. Molecular Cancer Research. 20 (4), pp. 596-606. https://doi.org/10.1158/1541-7786.MCR-20-0798